Jennifer Burstein
Direttore/Membro del Consiglio presso STOKE THERAPEUTICS, INC.
Patrimonio netto: - $ in data 30/06/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Huw Nash | M | 57 | 10 anni | |
| Ian Smith | M | 58 | 14 anni | |
| Adrian Krainer | M | 65 | 10 anni | |
| Seth Harrison | M | 63 | 9 anni | |
| David Bonita | M | 48 |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | 5 anni |
| John Kelley | M | 70 | 16 anni | |
| Kerry Clem | M | 54 | 13 anni | |
| Josh Bilenker | M | 52 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Arthur Levin | M | 70 | 9 anni | |
| Isabel Aznarez | M | 52 | 10 anni | |
| Arthur Tzianabos | M | 60 | 6 anni | |
| Julie Smith | F | 53 | 4 anni | |
| Garry Menzel | M | 59 | 4 anni | |
| Edward Kaye | M | 75 | 7 anni | |
| Peder Jensen | M | 69 | 13 anni | |
| Jonathan Allan | M | - | - | |
| Steven Elms | M | 60 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Avi Z. Naider | M | 52 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| David Schenkein | M | 66 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Aftab Kherani | M | 50 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Eric Rojas | M | - | - | |
| Dawn Kalmar | F | 47 | 5 anni | |
| Kristina Burow | F | 50 |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Joan Wood | F | - | 5 anni | |
| Shamim Ruff | F | 64 | 6 anni | |
| Barry Ticho | M | 64 | 7 anni | |
| Sunitha Ramamurthy | F | - | 6 anni | |
| Jeffrey Engelman | M | - |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | - |
| Doug Snow | M | - | 3 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Dov Goldstein | M | 56 | 2 anni | |
| Jeff Randall | M | 80 | 17 anni | |
| David Guyer | M | 64 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 5 anni |
| Robert Morales | M | 57 | 7 anni | |
| Lauren Sabella | F | 63 | 12 anni | |
| Barry Greene | M | 60 | 14 anni | |
| Nancy M. Wyant | F | - | 5 anni | |
| Christian Richardson | M | - | - | |
| Marty Glick | M | 74 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | - |
| Steven Harr | M | 53 | 3 anni | |
| Paul Chaney | M | 66 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 10 anni |
| Adrian L. Rabinowicz | M | - | 6 anni | |
| Tim Mayleben | M | 63 | 4 anni | |
| Robin A. Walker | M | 55 | 1 anni | |
| Kent Rogers | M | 54 | - | |
| Michael Barrett | M | 81 | 2 anni | |
| Brian Walter | M | - | - | |
| Todd F. Baumgartner | M | - | 5 anni | |
| Michelle Huie | F | - | - | |
| Brian W. Hutchinson | M | - | 5 anni | |
| Bonnie M. Pappacena | F | - | - | |
| Thomas C. Aquilina | M | - | - | |
| S. Michael Rothenberg | M | 54 | 5 anni | |
| Jennifer Low | M | 54 | 2 anni | |
| Rebecca R. Levine | F | - | 5 anni | |
| Enrique Carrazana | M | 62 | 5 anni | |
| Deborah Morosini | M | 65 | 3 anni | |
| Michael Samar | M | 51 | 3 anni | |
| Gene Liau | M | 69 | 4 anni | |
| Charles R. Allerson | M | 56 | 2 anni | |
| Meena | M | 51 | 4 anni | |
| Erin Campany | F | 57 | 4 anni | |
| Christopher Pierce | M | 44 | 2 anni | |
| Elizabeth Keating | F | - | - | |
| Soon H. Lee | M | - | - | |
| Katie Cairati | F | - | - | |
| Richard Batycky | M | 56 | - | |
| Joseph T. Kennedy | M | 56 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 anni |
| Enrique Dilone | M | 57 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 4 anni |
| Michael Rogers | M | 64 | 3 anni | |
| Glenn Sblendorio | M | 68 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 3 anni |
| Mary Fisher | F | 62 | 7 anni | |
| Wise Young | M | 74 | 16 anni | |
| Clare M. Carmichael | F | 64 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 anni |
| Emmett Cunningham | M | 63 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 4 anni |
| Loni da Silva | F | - |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 5 anni |
| Martin Freed | M | 63 | 1 anni | |
| Andrew Hindman | M | 51 | 5 anni | |
| Sam Hall | M | 42 | 5 anni | |
| Thomas Wessel | M | 68 | 3 anni | |
| Barrett Katz | M | 74 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 anni |
| Herbert Raymond Henney | M | - | 9 anni | |
| Evelyn Harrison | F | - |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 6 anni |
| Ruhi Khan | F | 49 | 5 anni | |
| Christopher Carroll | M | 57 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 1 anni |
| Stephen Tulipano | M | 65 | 5 anni | |
| Douglas Kargman | M | - | - | |
| Keith Westby | M | 49 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 87 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jennifer Burstein
- Contatti personali
